High Tower Advisors, LLC Immutep LTD Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$1.75 - $2.37 $21,001 - $28,442	12,001 New	12,001 $22,000
Q4 2022 Feb 08, 2023	BUY	$1.71 - $2.53 $17,100 - $25,299	10,000 New	10,000 $17,000
Q4 2021 Feb 10, 2022	SELL	$3.09 - $4.81 $61,800 - $96,199	-20,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.17 - $4.39 $12,680 - $17,560	4,000 Added 25.0%	20,000 $77,000
Q2 2021 Aug 06, 2021	SELL	$3.02 - $5.21 $78,520 - $135,460	-26,000 Reduced 61.9%	16,000 $62,000

Q1 2021 May 10, 2021	BUY	$2.37 - $3.68 $13,983 - $21,712	5,900 Added 16.34%	42,000 $129,000
Q4 2020 Feb 10, 2021	BUY	$1.64 - $5.69 $59,204 - $205,409	36,100 New	36,100 $114,000

2.28M

6.7K

114K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $163M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.